Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/5/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 10/5/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 10/5/22 | Issuer sale | Director | 62,923 | 0.0933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +82.98% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +103.69% | 53.03B | |
| -1.43% | -1.17% | +26.27% | +52.86% | 45.99B | |
| -0.48% | -2.80% | +18.01% | +117.99% | 42.45B | |
| +0.82% | +1.37% | +227.94% | +922.41% | 40.45B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +88.74% | 34.47B | |
| +0.09% | -1.75% | +23.02% | -10.89% | 24.23B | |
| Average | -0.05% | +4.29% | +52.43% | +162.67% | 43.62B | |
| Weighted average by Cap. | +0.08% | +3.59% | +49.29% | +160.56% |
Employees
457
